Gradian Diagnostics

Life Science

We provide advanced technologies for the sensitive detection, precise identification and thorough analysis of bacteria and fungi by molecular methods.

Precision in Molecular Diagnostics

At Gradian Diagnostics, we are at the forefront of life science innovation, dedicated to pushing the boundaries of what is possible in pathogen detection and microbiome analysis. We understand that the complexities of biological systems demand a highly sensitive, precise, and thorough approach, which is why we leverage cutting-edge molecular methods to provide unparalleled insights.

Precise Identification: Beyond Detection

Beyond simply detecting the presence of microorganisms, our molecular methods excel at their precise identification.

  • Single Pathogen Resolution: We can accurately pinpoint individual pathogens within a sample, providing clarity in cases where a single causative agent is suspected.
  • Deciphering Mixed Infections: For complex cases involving multiple pathogens, our technologies can effectively differentiate and identify each component of a mixed infection. This is crucial for guiding targeted treatments and preventing the development of drug resistance.

Research & Development

Revolutionizing Infectious Disease Diagnostics with Disruptive Molecular Technology
In the critical field of clinical diagnostics, the rapid and accurate identification of pathogens is paramount for effectively managing serious infections. At Gradian Diagnostics, our commitment to cutting-edge research and development is demonstrated through Gradian's unique, disruptive molecular technology, which is reshaping the diagnostic landscape.

The foundation of our technology is the patented MolYsis™ process, a crucial step that addresses one of the most significant challenges in molecular diagnostics: an abundance of human DNA in patient samples.

  1. Selective Host DNA Depletion: Our method first selectively lyses human host cells, leaving the microbial cells intact.
  2. Removal of Host DNA: A nuclease then degrades the released human DNA, which, if left untreated, would interfere with subsequent amplification steps and reduce sensitivity.
  3. Pathogen Enrichment and Isolation: Following this, the microbial cells are lysed, and their DNA is enriched and isolated. This process effectively removes inhibitors and yields a highly purified microbial DNA sample.